Stock listing
Adma Biologics Inc
Selected listing: ADMA · BX · CHF · CH
Adma Biologics Inc (BX Swiss: ADMA), Health Technology. Latest release Aug 7, 2026: ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline…
- Ticker
- BX Swiss: ADMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
About Adma Biologics Inc
The company focuses on developing and manufacturing specialty biologics for the treatment of infectious diseases. Adma Biologics aims to address unmet medical needs through its innovative products and therapies.
Latest news from Adma Biologics Inc
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
August 7, 2026
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
July 29, 2026
ADMA BIOLOGICS, INC. Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA
June 29, 2026
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026